FDA approves Endo's FORTESTA Gel for low testosterone

[News]

Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.

More... (http://www.news-medical.net/news/20101229/FDA-approves-Endos-FORTESTA-Gel-for-low-testosterone.aspx)